Ahụ ikePreparations

ATP: ntuziaka maka ojiji

Drug aha:

ATP-OGOLOGO oge (lat. ATP-ogologo).

Product ụdị:

ATP Long mbadamba onye na abụọ hundredths grams nke iri anọ mbadamba ke ngwugwu.

Pharmacological Action "ATP" nkwadebe ntuziaka maka ojiji kọwara dị ka ndị a:

akpụkpọ ahụ kwụsie ike, mgbochi ischemic n'ụlọnga. "ATP-Long" na ya Ọdịdị nwere ATP, amino asịd histidine, potassium na magnesium salts. A ọgwụ bụ ike nke na ngwa ngwa ike metabolism, iji weghachi chọrọ ịta nke potassium na magnesium ion, ntọt ke cell membranes ndị na usoro nke na-ahụ maka ion iga, melite antioxidant usoro nke na-echebe ndị myocardium. Ọzọkwa, ọgwụ ọjọọ, "ATP-Long" membranozavisimye ike rụọ ọrụ enzymes, weghachi ezi mejupụtara nke lipids na cell membranes na belata ịta nke uric acid. "ATP-Long" omume dị ka ihe antiarrhythmic, akpụkpọ ahụ na-emegide ischemic gị n'ụlọnga, n'ihi na nke ike iji dozie metabolic Filiks ke myocardium n'okpuru ọnọdụ nke hypoxia, ischaemia.

"ATP-Long" na-enye ntụziaka maka iji dị ka a ngwá ọrụ nwere ike melite hemodynamic parameters na Central na elu ọbara, melite gbasara obi mmepụta, obi muscle nwere ikike kpum na ọrụ nke ekpe ventricular ọrụ, na ya, mma nkịtị arụmọrụ nke ndị mmadụ. A ọgwụ bụ ike nke na rụọ ọbara na-obi nile, ọtọ ala nke uru ahụ nke obi, na-ebelata oriri nke gbasara obi muscle oxygen na ya ischemia, na dị ka a N'ihi ya, ibelata ugboro nke mwakpo nke rịaworo pectoris na iku ume ọkụ ọkụ attenuation n'okpuru nkịtị nchegbu. Ọrịa na paroxysmal supraventricular tachycardia, supraventricular tachycardia, atrial flutter ma ọ bụ atrial fibrillation, ọgwụ ọjọọ, "ATP-Long" bụ ike iji weghachi imi n'afọ iri na ụma, ma belata ọrụ (maka atrial na ventricular extrasystoles) ectopic foci.

Egosi maka "ATP" ngwaahịa ntụziaka ntuziaka na-enye ndị na-esonụ:

na ahụ ike na mgbagwoju megide ịrịa ọrịa obi, rịaworo, ma voltaji na izu-ike, asị ibe na Baịbụl hiwere isi n'ebe Cardiosclerosis, mgbe myocardial na myocarditis, paroxysmal supraventricular tachycardia na supraventricular na ndị ọzọ na arrhythmias, myocardial dystrophy, myocarditis, IRR. Ọzọkwa, ọ na-kenyere iche iche Jenesis hyperuricemia, welie ndidi ka anụ ahụ exertion na na mmepe nke ọrịa oké ike ọgwụgwụ.

The usoro, nke ga-eji dị otú ahụ dị ka "ATP", ọgwụ na a nkwadebe ndu na-atụ aro ndị na-esonụ:

inye ya atọ - ugboro anọ kwa ụbọchị na a dose n'etiti iri na iri na iri anọ milligrams. The nkezi ọgwụgwọ ekwupụtakwa na iri abụọ ka ụbọchị iri atọ, ma ọ bụrụ na ọ dị mkpa, ọgwụgwọ nwere ike ugboro ugboro mgbe iri - iri na ise ụbọchị. The kacha dose kwa ụbọchị anọ - narị isii milligrams. Mbadamba "ATP" ẹka sublingually na igbari kpamkpam, na-iri ọgwụ adịghị.

Mmetụta nke ọgwụ "ATP" ntụziaka ntuziaka na-akọwa ndị a:

ọgbụgbọ, iche iche allergies, wetara sensashion na epigastric. Ọ bụrụ na ọgwụgwọ na-ewe a ogologo oge na-adịghị achịkwa, o nwere ike ịzụlite hyperkalemia na gipermagniemiya.

Contraindications ọgwụ "ATP" ntụziaka ntuziaka na-akọwa ndị na-esonụ:

nnukwu myocardial infarction, hyperkalemia, gipermagniemiya, oké ụkwara ume ọkụ, AV-ngọngọ nke abụọ - atọ ogo, hemorrhagic ọrịa strok, hypersensitivity ọgwụ, afọ ime, lactation.

Drug ovadozu:

ike ịzụlite atrioventricular ngọngọ, hypotension, bradycardia. Na ndị a, ọgwụ na-kagbuo, ịbụ symptomatic ọgwụ, na ẹkenam n'oge mmepe nke bradycardia atropine sulfate.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 ig.unansea.com. Theme powered by WordPress.